http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019167475-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8306bed35d2208472595d476a1c6cdf4
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00736
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2009-00891
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M27-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0612
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-007
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00781
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16
filingDate 2019-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_082f5be54d82aa874b96eb6783477dcd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8609e9bf17f0c31a821ef74961938c6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b579acbf70862b9883b6d98246f5ffd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_964900bf1d15439a54d049df329f7b49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44ca19a5b81ef7fa59324f2881c2647e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fdceb608fbcd8ff4381b0f3a610a61a
publicationDate 2019-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2019167475-A1
titleOfInvention Adjustable intraocular implant
abstract Methods and devices for adjusting or configuring the flow rate of an intraocular shunt are provided whereby hypotony can be avoided by increasing the flow rate through the device. In some embodiments, the device is a shunt that can have a first flow that can be modified to a second flow by modifying the shunt, such as by cutting the shunt. Additionally, one or more dissolvable portions can be present to provide an initial flow restriction and subsequent increase in flow over time.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11737920-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11058581-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11166848-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11166849-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11517477-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11529258-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11596550-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11291585-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023081356-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11766355-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023081365-A1
priorityDate 2013-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24847876
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15908
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5746
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449564043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394123
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945

Total number of triples: 44.